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ABSTRACT 
The present study deals with the isolation of fourteen compounds from the active ethyl acetate 
(MPE) extract of M. pudica (L.) whole plant and their subsequent evaluation for the nitric ox-
ide (NO), tumor necrosis factor alpha (TNF-α) and interleukin 1 beta (IL-1β) inhibitory ac-
tivities in lipopolysaccharide (LPS) stimulated RAW 264.7 and J774A.1 cells. Among the 
tested compounds, L-mimosine (12; IC50 = 19.23 to 21.15 μM), crocetin (4; IC50 = 23.45 to 
25.57 μM), crocin (14; IC50 = 27.16 to 31.53 μM) and jasmonic acid (11; IC50 = 21.32 to 
29.42 μM) were identified as potent NO inhibitor when tested on the macrophages. Similarly, 
towards TNF-α and IL-1β inhibition, including these four compounds, and  ethyl gallate (3), 
gallic acid (10) and caffeic acid (7) were found to be more active with half maximal concen-
tration, 17.32 to 62.32 µM whereas the other compounds depicted moderate and mild effects 
(IC50 = 59.32 to 95.01 μM). Also, at a dose of 40 mg/Kg, L-mimosine (12), jasmonic acid 
(11), crocin (14) and its de-esterified form, crocetin (4) were found to significantly (p < 0.05 
and 0.001) reduce 60.7 %, 48.9 %, 48.4 % and 43.6 % respectively of TNF-α production in 
female Sprague Dawley rats. However, in case of IL-1β, with the same dose (40 mg/Kg), 
jasmonic acid (11) exhibited significant reduction with 54.2 % followed by crocin (14) 
(50.2 %) and crocetin (4) (39.8 %) while L-mimosine (12) was found to reduce only 16.3 %. 
Based on the results, it can be estimated that these compounds imparting greatly to anti-
inflammatory effects of M. pudica in vitro as well as in vivo through reduction of LPS-
induced pro-inflammatory mediators which affirm the ethno-pharmacological use of this plant 
for prevention of inflammatory-related disorders.  
 





Many pathological processes such as in-
flammation, necrosis, fibrosis and apoptosis 
normally required the cytokines. Binding of 
Gram negative bacterial endotoxin or lipo-
polysaccharide (LPS) to CD14 (a protein) in-
itiates an inflammatory cytokine and other 
mediators which in turn, act on neutrophils, 
macrophages, endothelial cells and Kupffer 
cell to produce an array of pro-inflammatory 
cytokines such as interferon gamma (IFN-γ), 
tumor necrosis factor alpha (TNF-α), inter-
leukin 1 beta (IL-1β), interleukin 6 (IL-6) 
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and nitric oxide (NO) (Good et al., 1998). 
Serious side effects of the approved synthetic 
antibodies (etanercept, infliximab and ada-
limumab) for inflammatory conditions 
providing impetus to alternative small mole-
cule based therapies towards TNF-α inhibi-
tion (Palladino et al., 2003).  
Mimosa pudica L. (Fabaceae) reported to 
have anti-diabetic (Marles and Farnsworth, 
1995), hyperglycemic (Amalraj and Ignaci-
muthu, 2002), antidepressant (Molina et al., 
1999), anticonvulsant (Bum et al., 2004), ac-
etylcholinestrase inhibitory (Mukherjee et 
al., 2007), anti-ophidian, anti-venom (Ma-
hanta and Mukherjee, 2001; Girish et al., 
2004; Ambikabothy et al., 2011), wound 
healing (Kokane et al., 2009) and antifertility 
(Ganguly et al., 2007) activities.  
In the continuous search for newer anti-
inflammatory leads from natural products, 
many plant extracts, isolated compounds or 
their derivatives have been tested for their 
inhibitory effects towards pro-inflammatory 
cytokines (Patel et al., 2014; Patel and Bhu-
tani, 2014; Bhandari et al., 2014a; b). Previ-
ously, we demonstrated that ethyl acetate ex-
tract (MPE) of M. pudica whole plant have 
significant inhibition of NO, TNF-α and IL-
1β production in RAW 264.7 cells with an 
IC50 of 34.4, 31.7 and 47.2 µg/mL respec-
tively (Patel et al., 2014). Hence, the present 
study was carried out to isolate and charac-
terize compounds from standardized MPE 
and then subsequent evaluated for NO, TNF-
α and IL-1β inhibitory effects on RAW 
264.7 and J774A.1 cells.  
 
MATERIALS AND METHODS 
Plant material 
Whole plant of Mimosa pudica (L.) were 
collected from the region of Jabalpur, Madh-
ya Pradesh, India in January, 2011 and au-
thenticated by Dr. A. S. Sandhu (botanist) of 
the Department of Natural products (DNP), 
National Institute of Pharmaceutical Educa-
tion and Research (NIPER) and a voucher 
specimen (NIP-NPM-CD-019) was deposit-
ed in the herbarium of DNP, NIPER, SAS 
Nagar, Punjab, India. The plant materials 
were shade dried for 10 days followed by 
pulverization and sieving (20-30 mesh). 
 
Instruments 
Ultraviolet (UV) and Mass spectra were 
taken on a DU® 7400 spectrophotometer 
(Beckman, München, Germany) and mass 
spectrometer (Thermo Quest Finnigan, San 
Jose, CA, USA) respectively. 1H and 13C 
Nuclear magnetic resonance (NMR) spectra 
were recorded on Ultrashield 400 MHz and 
100 MHz spectrometer respectively (Bruker 
DPX, Faellanden, Germany). High perfor-
mance Liquid chromatography (HPLC) 
analysis for compound analysis was carried 
out on Novapak C18 column (5 μm, 4.6 x 
250 mm). Ultracentrifuge (Sigma, St. Louis, 
MO, USA), CO2 incubator (WTC Binder, 
Tuttlingen, Germany), Biosafety cabinet 
(Clean air, Chennai, India), autopipettes, 
ELISA plate reader (Labsystems, Helsinki, 
Finland) and Neubauer chamber (HBG, 
Gießen, Germany) were used for the cell cul-
ture. All extracts and fractions were concen-
trated using a vacuum rotary evaporator (Bu-
chi R-210, Flawil, Switzerland).  
 
Chemicals and reagents 
Fetal bovine serum (FBS), Dulbecco’s 
modified Eagle’s medium (DMEM), 3-(4,5-
dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetra-
zolium bromide (MTT), phosphate buffered 
saline (PBS), antibiotic solution and other 
chemicals were purchased from Hi-media 
Limited (Mumbai, India). Silica gel (# 100-
200 and # 230-400) from Loba Chemie 
(Mumbai, India), Diaion HP-20® resin from 
Supelco analytical (USA), Sephadex LH-20 
from Amersham Pharmacia Biotech and GE 
Healthcare (USA), Polyamide 6 and RP18 
column from Sigma Chemical Co. (St. Lou-
is, MO, USA) were used for column chroma-
tography. Mouse and rat TNF-α and IL-1β 
ELISA kits were obtained from Krishgen 
Biosystems (Mumbai, India). Thin layer 
chromatography (TLC) plates pre-coated 
with silica gel 60 F254 thickness 0.2 mm and 
solvents (laboratory grade) were received 
from Merck (Darmstadt, Germany). Dexa-
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methasone, Lipopolysaccharide (Escherichia 
coli 026:B6) (LPS), dimethyl sulfoxide 
(DMSO), curcumin, L-NG-Nitroarginine me-
thyl ester (L-NAME), modified Griess rea-
gent, L-mimosine, jasmonic acid and crocin 
were obtained from Sigma Chemical Co. (St. 
Louis, MO, USA). For in vivo study, L-
mimosine, jasmonic acid and crocin were 
purchased from Sigma Chemical Co. (St. 
Louis, MO, USA) and crocetin was prepared 
by ester hydrolysis of crocin. 
 
Extraction and isolation  
Dried and pulverized whole plant (3.2 
kg, 20-30 mesh) subjected to sequential 
maceration with 6 L (3x) hexanes (Hex), di-
chloromethane (DCM), ethyl acetate 
(EtOAc) and methanol (MeOH) for 72 h at 
25 °C to yield hexanes (MPH, 15 g), di-
chloromethane (MPD, 11 g), ethyl acetate 
(MPE, 38 g) and methanol (MPM, 17 g) ex-
tracts respectively. Vacuum liquid chroma-
tography (VLC) of MPE (37 g) over silica 
gel (230-400 mesh) column chromatography 
(CC) was performed using a stepwise gradi-
ent of hexanes containing increasing 
amounts of EtOAc (from 0 % up to 100 %) 
and then finally washed with 50 % MeOH. 
On the basis of similar thin layer chromatog-
raphy (TLC) profiles, five pooled fractions 
(Fr); F1 (5.2 g, 0-25 % EtOAc/Hex), F2 
(8.6 g, 25-50 % EtOAc/Hex), F3 (5.1 g, 50-
75 % EtOAc/Hex), F4 (5.9 g, 75-100 % 
EtOAc/Hex), F5 (10.5 g, 100 % EtOAc to 
50 % MeOH/EtOAc) were obtained and they 
were further subjected to CC using Diaion 
resin HP-20 for removal of chlorophyll. Pu-
rification of MPE-F2 (8.6 g) with CC over 
silica gel (230-400 mesh) and then with se-
phadex LH-20 in MeOH provided 1(19 mg), 
2 (13 mg) and 3 (27 mg). Similarly, follow-
ing the same procedure, 4 (26 mg), 5 (18 
mg), 6 (30 mg) and 7(22 mg) were obtained 
from MPE-F3 (5.1 g). MPE-F4 (5.9 g) when 
subjected to repeated sephadex LH-20 chro-
matography in MeOH yielded 8 (13 mg) and 
9 (32 mg). Polar fraction MPE-F5 (10.5 g) 
was fractionated by Polyamide 6 CC using 
H2O/MeOH gradient to provide four sub-
fractions (MPE-F5a-d). 10 (12 mg), 11 
(10 mg) and 12 (19 mg) were obtained from 
MPE-F5a-c after CC with repetitive se-
phadex LH-20 in MeOH. Similarly, MPE-
F5d was subjected to Sephadex LH-20 and 
RP18 CC to give 13 (13 mg) and 14 (45 mg). 
All the compounds were found to be 97-
99 % when analyzed by HPLC. 
 
HPLC condition  
HPLC analysis was carried out on a Wa-
ters 600 Controller equipped with Waters 
996 photodiode array (PDA) detector using a 
Novapak C18 column (4.6 × 250 mm, 5 μm) 
included with 717-Autosampler & Inline de-
gasser. The mobile phase consisted of sol-
vent A, 0.1 % trifluoroacetic acid in acetoni-
trile and B, 0.1 % trifluoroacetic acid in wa-
ter and performed gradient elution. The flow 
rate was 1 mL/min and chromatogram ex-
tracted at 290 nm. The mobile phase consists 
of solvent A, acetonitrile (ACN) and B, 
0.4 % formic acid in water. Gradient elution 
was carried out starting from 95 to 90 % of B 
in 5 min, from 90 to 85 % of B in 3 min, 
from 85 to 80 % of A in 2 min, from 80 to 
78 % of B in 2 min, from 78 to 76 % of B in 
1 min, from 76 to 74 % of B in 1 min, from 
74 to 73 % of B in 2 min, from 73 to 72 % of 
B in 2 min, from 72 to 65 % of B in 1 min, 
from 65 to 50 % of B in 3 min and finally 
from 50 to 40 % of B in 2 min. Fully dried 
MPE (5 mg/mL w/v) and 1, 2, 3, 9 and 10 
(1 mg/mL w/v) were dissolved in HPLC 
grade MeOH and then filtered through 
0.22 µm membrane filter. 
 
Cell culture 
RAW 264.7 and J774A.1 cells were ob-
tained from the National Centre for Cell Sci-
ence (NCCS, Pune, India) and were cultured 
in 250 ml culture flasks containing DMEM 
media supplemented with heat inactivated 
10 % FBS, 10,000 units/mL penicillin and 
10 mg/mL streptomycin in 0.9 % saline, in a 
CO2 incubator (5 % CO2 in air) at 37 °C. 
Test samples were dissolved in DMSO/Mil-
li-Q water and stored at 4 °C until pharmaco-
logical analysis. 
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Cell viability  
Cell viabilities for RAW 264.7 and 
J774A.1 cells were performed according to 
the method recently used by us (Patel and 
Bhutani, 2014). Briefly, 10,000 cells per 
well/200 μL were incubated with DMEM 
(10 % FBS) for 24 h with test samples and 
then cell viability was measured using the 
MTT assay. 
 
NO inhibitory assay  
NO inhibitory assay was performed using 
the Griess reaction according to method re-
cently used by us (Patel et al., 2014). A NO 
release in the culture medium was quantified 
using Griess reaction. Briefly, cells were pre-
incubated with different concentrations of 
the test samples for 1 h, and then were stimu-
lated with 1µg/mL of LPS (Escherichia coli 
026:B6) in a 96 well microtitre plate. After 
incubation at 37 °C for 24 h in an atmos-
phere of 5 % CO2 and 95 % humidity, 
100 µL of modified Griess reagent was add-
ed to 100 µL supernatant. After 30 min of 
incubation, the optical density (OD) was 
measured by using a 96 well microtitre plate 
reader at 540 nm and compared with the 
standards used (curcumin and L-NAME). 
 
TNF-α and IL-1β assays 
The production of cytokines in the su-
pernatants was quantified by sandwich im-
munoassays using the protocol supplied by 
the manufacturer (Krishgen Biosystems, 
Mumbai, India) and also as previously de-
scribed by us (Patel and Bhutani, 2014). 
Briefly, cells was subjected with different 
concentrations of the test samples for 1 h, 
and then induced with 1µg/mL of LPS 
(Escherichia coli 026:B6) in a 96 well mi-
crotitre plate. In case of TNF-α and IL-1β, 
the cells were further incubated for 6 h and 
12 h, respectively. Cytokines levels were 
measured in supernatants following the in-
struction manual supplied in sandwich ELI-
SA kits at 450 nm (Krishgen Biosystems, 
Mumbai, India) and compared with the 
standards used (curcumin and dexame-
thasone).  
Measurement of TNF-α and IL-1β  
production in plasma of SD rats 
The experimental study was approved by 
the Institute Animal Ethics Committee 
(IAEC) under approval number IAEC/13/46 
and performed according to the guidelines of 
the Committee for the Purpose of Control 
and Supervision of Experiments on Animals 
(CPCSEA) given on animal experimentation. 
Female Sprague Dawley (SD) rats (200-
250 g, n = 5 in each group) were issued from 
the Central Animal Facility (CAF), NIPER 
and separated into three different groups 
(control, test and a positive control group) 
and were permitted to have free water and 
normal diet ad libitum. Cytokines (TNF-α 
and IL-1β) concentrations were determined 
as per the method previously described by us 
(Patel and Bhutani, 2014). Briefly, a control 
group received p. o. vehicle (10 % Tween 
80), test group received MPE (50, 100 and 
400 mg/Kg), L-mimosine (12), crocin (14), 
crocetin (1) and jasmonic acid (11) (20 and 
40 mg/Kg each) and a positive control group 
received dexamethasone (5 mg/Kg) respec-
tively at an interval of 12 h. LPS (5mg/Kg) 
was administered i. p. after 2 h of the final 
dose. After LPS administration, blood sam-
ples were collected later 2 h and 6 h in case 
of TNF-α and IL-1β respectively. Animals 
were monitored for any unusual behavior 
and signs of toxicity at treated doses of test 
samples. Sandwich ELISA kits specific for 
rats were used to determine the cytokines 
(TNF-α and IL-1β) levels in the plasma. 
 
Statistical analysis 
The results are shown as the mean ± SD 
and all experiments were performed in tripli-
cates. Statistical treatment was carried by 
One-Way ANOVA preceded by a Dunnett’s 
post test (commercially available software 
SigmaStat 3.5). A level of p < 0.05 or 0.001 
was used as the criterion of statistical signif-
icance. 
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RESULTS AND DISCUSSION 
Characterization of isolated compounds 
Chemical investigation of MPE led to the 
isolation of fourteen compounds (Figure 1) 
namely crocetin (4), crocin (14) (Van 
Calsteren et al., 1997), 6-hydroxy flavone 
(2), 2'-hydroxy flavanone (1) (Freeman et al., 
1981), p-hydroxy benzoic acid (5), p-
coumaric acid (6) (Durust et al., 2001), 
chlorogenic acid (8) (Ahmad, 2010), 
jasmonic acid (11) (Husain et al., 1993) and 
L-mimosine (12) (Nokihara et al., 2012) 
which were identified and characterized by 
comparison of their physicochemical and 
spectral data with that reported in the litera-
ture. Caffeic acid (7), ethyl gallate (3), cate-
chin (9), gallic acid (10), and tyrosine (13) 
were identified by co-TLC with the authentic 
standards available in our laboratory and MS 
spectrometry. Further, HPLC profile for 
EtOAc fraction of Mimosa pudica (L.) whole 
plant showed the presence of major com-
pounds. The compounds 1, 2, 3, 9, and 10 
eluted at retention time (Rt) 32.32, 30.76, 
20.19, 17.99 and 5.88 corresponds to 2'-
hydroxy flavanone, 6-hydroxy flavone, ethyl 
gallate, catechin and gallic acid respectively 
(Figure 2). 
 
Inhibitory effects of isolated compounds on 
NO and cell viability in macrophages 
With respect to NO inhibition, in com-
parison to other tested compounds and also 
to nitric oxide synthase inhibitor (L-NAME), 
L-mimosine (12; IC50 = 19.23 ± 1.53 and 
21.15 ± 1.36 μM) a toxic non-protein free 
amino acid, crocetin (4; IC50 = 23.45 ± 2.62 
and 25.57 ± 2.47 μM) and its ester crocin 
(14; IC50 = 27.16 ± 4.51 and 31.53 ± 1.25 
μM) and jasmonic acid (11; IC50 = 29.42 ± 
1.65 and 21.32 ± 1.35 μM) a plant hormone, 
exhibited the prominent activity on RAW 
264.7 cells and J774A.1 cells respectively. 
However, Caffeic acid (7) exhibited highest 
NO inhibition on RAW 264.7 cells 
(IC50 = 19.20 ± 4.97 μM) while found to be 
merely active (IC50 = 78.01 ± 3.94 μM) on 
J774A.1 cells. Compounds, 6-hydroxy fla-
vone (2), 2'-hydroxy flavanone (1), p-
coumaric acid (6) and ethyl gallate (3) were 
also demonstrated moderate and modest in-
hibition towards NO release with an IC50 
ranging from 42.31 ± 3.15 to 69.21 ± 2.77 
μM on the both cells. Tyrosine (13) being a 
primary metabolite was excluded from the 
study. All the tested compounds were found 
to be non-cytotoxic except L-mimosine (12) 
when tested at maximum concentration of 
100 μM (cell viability > 80 %) (Table 1A). 
 
Inhibitory effects of isolated compounds  
on pro-inflammatory cytokines in macro-
phages 
We further screened the isolated com-
pounds for their inhibitory potential against 
pro-inflammatory cytokines (TNF-α and IL-
1β). As shown in Table 1(B), on RAW 264.7 
cells and J774A.1 cells, TNF-α inhibition 
follows the order: ethyl gallate (3; IC50 = 
17.32 ± 4.61 and 23.45 ± 2.67 µM) and cro-
cetin (4; IC50 = 20.36 ± 2.48 and 22.21 ± 
3.83 μM) > crocin (14; IC50 = 22.41 ± 1.08 
and 25.21 ± 2.56 μM) > gallic acid (10; 
IC50 = 23.81 ± 2.14 and 29.33 ± 3.12 μM 
> L-mimosine (12; IC50 = 25.24 ± 2.48 and 
25.21 ± 2.56 μM > jasmonic acid (11; 
IC50 = 39.42 ± 2.85 and 41.36 ± 1.67 μM) 
> caffeic acid (7; IC50 = 45.01 ± 1.93 and 
49.61 ± 1.33 μM) respectively whereas the 
other compounds depicted moderate and 
mild effects with half maximal concentration 
grading from 59.32 ± 1.76 to 89.34 ± 1.38 
μM. With respect to IL-1β inhibition, except 
for L-mimosine (12), similar activity pattern 
was accompanied for these compounds; 
ethyl gallate (3; IC50 = 36.92 ± 3.35 and 
39.52 ± 2.86 µM) and crocin (14; IC50 = 
29.23 ± 3.69 and 31.15 ± 2.64 μM) followed 
by crocetin (4; IC50 = 35.43 ± 2.34 and 41.15 
± 1.69 μM), gallic acid (10; IC50 = 42.11 ± 
3.62 and 47.64 ± 1.67 μM, L-mimosine (12; 
IC50 = 64.23 ± 2.53 and 65.76 ± 1.86 μM, 
jasmonic acid (11; IC50 = 57.92 ± 0.61 and 
59.24 ± 2.25 μM), caffeic acid (7; 
IC50 = 59.34 ± 2.94 and 62.32 ± 2.94 μM) 
were found to be more active on RAW 264.7 
cells and J774A.1 cells respectively as com-
pare to other tested compounds. 
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Figure 2: HPLC profile for EtOAc fraction of Mimosa pudica L. leaves. The compounds 1, 2, 3, 9, and 
10 eluted at retention time (Rt) 32.32, 30.76, 20.19, 17.99 and 5.88 corresponds to 2'-hydroxy fla-
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Table 1A: Cell viability and NO inhibitory effects of isolated compounds from M. pudica 
Compound 
Cell viabilitya (% of control) IC50 ( µM ) for NO inhibition 
RAW 264.7 J774A.1 RAW 264.7 J774A.1 
2'-hydroxy flavanone (1) 96.12 ± 3.23 91.14 ± 1.82 71.25 ± 2.41 74.06 ± 1.85 
6-hydroxy flavone (2) 92.33 ± 2.21 94.28 ± 3.36 61.15 ± 3.52 69.21 ± 2.77 
Ethyl gallate (3) 94.12 ± 1.47 93.22 ± 2.35 67.20 ± 2.17 61.34 ± 2.34 
Crocetin (4) 90.23 ± 1.01 92.84 ± 1.64 23.45 ± 2.62 25.57 ± 2.47 
p-hydroxy benzoic acid (5) 81.34 ± 1.83 83.89 ± 3.71 43.11 ± 2.03 49.29 ± 1.72 
p-coumaric acid (6) 94.62 ± 4.92 92.52 ± 1.14 42.31 ± 3.15 55.31 ± 2.17 
Caffeic acid (7) 88.23 ± 1.35 87.47 ± 2.64 19.20 ± 4.97 78.01 ± 3.94 
Chlorogenic acid (8) 87.23 ± 1.32 88.81 ± 1.34 82.45 ± 1.34 87.23 ± 2.56 
Catechin (9) 95.31 ± 1.49 92.21 ± 3.21 98.81 ± 4.95 99.34 ± 2.38 
Gallic acid (10) 91.13 ± 2.36 92.41 ± 3.75 78.81 ± 5.21 82.34 ± 1.46 
Jasmonic acid (11) 83.19 ± 3.54 90.78 ± 1.48 29.42 ± 1.65 21.32 ± 1.35 
L-mimosine (12) 73.24 ± 1.42 77.82 ± 2.81 19.23 ± 1.53 21.15 ± 1.36 
Crocin (14) 92.32 ± 2.15 93.42 ± 1.43 27.16 ± 4.15 31.53 ± 1.25 
L-NAMEb - - 69.21 ± 1.31 73.18 ± 1.70 
Curcuminb - - 11.02 ± 2.40 18.52 ± 2.89 
Values are presented as mean ± S. D. of three different experiments in triplicates.  
aCell viability was measured at concentration of 100 μM.  
bStandards used for the present study. 
 
 
Table 1B: TNF-α and IL-1β inhibitory effects of isolated compounds from M. pudica  
Compound 
IC50 ( µM ) for inhibition of 
TNF-α IL-1β 
RAW 264.7 J774A.1 RAW 264.7 J774A.1 
2'-hydroxy flavanone (1) 89.02 ± 1.42 84.30 ± 1.54 92.01 ± 1.32 95.01 ± 3.28
6-hydroxy flavone (2) 71.12 ± 2.23 69.37 ± 2.57 75.31 ± 1.43 77.31 ± 2.37
Ethyl gallate (3) 17.32 ± 4.61 23.45± 2.67 36.92 ± 3.35 39.52 ± 2.86
Crocetin (4) 20.36 ± 2.48 22.21 ± 3.83 35.43 ± 2.34 41.15 ± 1.69
p-hydroxy benzoic acid (5) 81.31 ± 1.80 82.91 ± 1.83 90.81 ± 1.23 89.32 ± 1.73
p- coumaric acid (6) 59.32 ± 1.76 62.31 ± 2.43 67.15 ± 2.83 70.34 ± 1.42
Caffeic acid (7) 45.01 ± 1.93 49.61 ± 1.33 59.34 ± 2.94 62.32 ± 2.94
Chlorogenic acid (8) 67.91 ± 1.34 71.23 ± 1.45 78.21 ± 2.05 81.72 ± 1.76
Catechin (9) 81.48 ± 3.19 89.34 ± 1.38 83.73 ± 0.08 89.50 ± 2.83
Gallic acid (10) 23.81 ± 2.14 29.33 ± 3.12 42.11 ± 3.62 47.64 ± 1.67
Jasmonic acid (11) 39.42 ± 2.85 41.36 ± 1.67 57.92 ± 0.61 59.24 ± 2.25
L-mimosine (12) 25.24 ± 2.48 27.82 ± 1.18 64.23 ± 2.53 65.76 ± 1.86
Crocin (14) 22.41 ± 1.08 25.21 ± 2.56 29.23 ± 3.69 31.15 ± 2.64
Dexamethasonea 0.04 ± 3.10 0.42 ± 2.16  4.71 ± 1.52 22.95 ± 3.25
Curcumina 3.41± 2.38  5.64± 0.25 17.51 ± 1.57 67.45 ± 1.31
Values are presented as mean ± S. D. of three different experiments in triplicates.  
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Inhibitory effects of crocetin (4), crocin 
(14), jasmonic acid (11) and L-mimosine 
(12) on pro-inflammatory cytokines in SD 
female rats 
In view of in vitro anti-inflammatory ef-
fects of crocetin (4), crocin (14), jasmonic 
acid (11) and L-mimosine (12), MPE and 
these compounds were further evaluated in 
female SD rats for in vivo inhibition of pro-
inflammatory cytokines. Ethyl gallate (3) 
and gallic acid (10)) have also shown promi-
nent inhibition of pro-inflammatory media-
tors in vitro (Table 1 B). However, these 
were already reported to have such activity 
in in vivo models and hence, excluded from 
the present in vivo study (Hsiang et al., 2013; 
Mehla et al., 2013). The subjection of LPS 
or/and test samples in animals was not found 
to cause any unnatural behavior and perni-
ciousness at tested doses. As shown in Fig-
ure 3 (A & B) there is a substantial increase 
(p < 0.001) in the TNF-α (1623 pg/mL) and 
IL-1β (912 pg/mL) levels in the LPS induced 
groups with respect to the normal group 
(< 87 pg/mL). Dexamethasone (standard 
drug) at a dose of 5 mg/kg was found to sup-
press significantly (p < 0.001) TNF-α pro-
duction by 75.8 % (394 pg/mL) and IL-1β 
production by 63.0 % (338 pg/mL) respec-
tively. MPE at treated dose of 50, 100 and 
400 mg/Kg manifested significant (p < 0.05 
and 0.001) reduction of TNF-α levels by 
18.4, 39.3 and 61.9 % and IL-1β levels by 
10.5, 26.3 and 54.8 % respectively. Com-
pounds, 4, 14, 11 and 12 were tested at two 
doses viz. 20 and 40 mg/Kg for pro-
inflammatory cytokines inhibition. At dose 
of 40 mg/kg, L-mimosine (12) was found to 
be most active with significant (p < 0.05 and 
0.001) reduction of TNF-α production by 
60.7 % (639 pg/mL) preceded by jasmonic 
acid (11) 48.9 % (830 pg/mL), crocin (14) 
48.4 % (836 pg/mL) and its de-esterified 
form, crocetin (4) 43.6 % (914 pg/mL). 
However, in case of IL-1β, with the same 
dose (40 mg/kg), jasmonic acid (11) exhibit-
ed significant reduction with 54.2 % (418 pg/ 
mL) followed by crocin (14) (50.2 %; 
456 pg/mL) and crocetin (4) (39.8 %; 
549 pg/mL) while L-mimosine (12) was 
found to reduce only 16.3 % (763 pg/mL). 
Results indicated that these compounds im-
parting greatly to anti-inflammatory effects 
of MPE in vitro as well as in vivo through 
reduction of LPS-induced pro-inflammatory 
mediators.  
Nam et al. (2010) showed that crocin 
(14) and crocetin (4) provide protection 
against neuroinflammation by reducing the 
production of LPS-induced NO release, 
TNF-α, IL-1β, and intracellular reactive ox-
ygen species (ROS) in cultured rat brain mi-
croglial cells. Methyl jasmonate and its α-
haloenone derivatives were also reported as 
anti-inflammatory agents (Dang et al., 2008). 
Yang et al. (2011) has reported the anti-
asthmatic effects of M. pudica extract via 
suppression on airway inflammation associ-
ated with the regulation of IL-5 and IgE ex-
pression. Also, L-mimosine (12) depicted 
anti-inflammatory effect on TNF-α and IL-6 
production in supernatant fluids of minced 
granulomas (Frydas et al., 2003). Recently, 
caffeic acid (7) present in Propolis demon-
strated suppression of LPS-induced pro-
inflammatory response by blocking nuclear 
factor-kappa B (NF-κB), c-Jun N-terminal 
kinase (JNK1/2) and p38 mitogen activated 
protein kinase (MAPK) activation in macro-
phages (Búfalo et al., 2013). Gallic acid (10) 
also reported to have inhibitory effects on 
LPS-induced inflammation in NF-κB trans-
genic mice (Hsiang et al., 2013). Taking the 
above findings together, it can be assumed 
that mostly crocetin (4) and crocin (14), 
jasmonic acid (11) and L-mimosine (12), 
caffeic acid (7), ethyl gallate (3) and gallic 
acid (10) present in the ethyl acetate fraction 
of whole plant of M. pudica imparted greatly 
to its anti-inflammatory effect via suppres-
sion of NO, TNF-α and IL-1β levels which 
may be partly due to their synergistic mech-
anisms. 
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Figure 3: Inhibitory effects of tested samples on plasma levels of (A) TNF-α and (B) IL-1β in female 
SD rats {* (p < 0.001) = vs control; # (p < 0.05), ## (p < 0.001) = vs LPS}. Values are expressed as 
mean ± SD; n = 5 animals. The data was analyzed by One way of ANOVA test followed by Dunnett’s 
test. LPS: lipopolysaccharide, MPE: ethyl acetate extract of M. pudica, Cre: crocetin (4), Cro: crocin 
(14), JA: jasmonic acid (11), Mim: L-mimosine (12), Dex: dexamethasone 
 
In conclusion, the present investigation 
revealed the in vitro and in vivo anti-
inflammatory effects of M. pudica through 
the suppression of pro-inflammatory cyto-
kines and NO which affirm the ethno-
pharmacological use of this plant for preven-
tion of inflammatory-related disorders.  
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